Measuring Biological Capabilities and Risks of AI Agents
Patricia Paskov, Jeffrey Lee, Kyle Brady, Alyssa Worland
Why It Matters
What makes this one worth your time
Understanding the biological implications of AI systems is crucial for policymakers and researchers to make informed decisions regarding biosecurity and funding.
Evaluating AI agents' biological risks requires careful design and interpretation of evaluation metrics.
Summary
The paper discusses the evaluation of biological capabilities and risks associated with AI agents, emphasizing the importance of design choices in interpreting evaluation results and providing practical considerations for policymakers and researchers.
Key contributions
- Synthesis of current evidence on AI-enabled biological risks.
- Introduction of biological agentic evaluations as a tool for assessing AI systems.
- Practical considerations for defining and documenting evaluations to improve interpretation.
Notable insights
- The paper highlights the sensitivity of evaluation results to design choices, which is often overlooked in AI assessments.
- It proposes a framework for biological agentic evaluations that could guide future research and funding decisions.
Possible limitations
- Not stated in the abstract.
Abstract
arXiv:2606.19899v1 Announce Type: cross Abstract: This paper addresses a rapidly emerging policy challenge: how to generate and interpret credible evidence about the biological capabilities and risks of AI scientists, or agentic AI systems capable of autonomously or collaboratively performing multi-step scientific tasks. As these systems enter real research workflows, decision-makers increasingly face evaluation results whose meaning depends on underlying design choices that are often implicit or under-documented. We synthesize current evidence on AI-enabled biological risks and introduce biological agentic evaluations as a promising, but interpretation-sensitive, tool for assessing these systems. Our central contribution is a set of practical, experience-grounded considerations -- drawing from our own evaluations -- that show how choices around defining, designing, running, scoring, and documenting evaluations materially shape what results do and do not imply about risk. The analysis is intended to help policymakers interpret biological evaluation outputs with appropriate caution; guide public and private funders toward high-leverage investments in AI-biology evaluation research; and support biosecurity practitioners assessing emerging AI systems. A secondary audience includes researchers designing or conducting agentic evaluations within frontier AI labs, AI providers, scientific institutions, and third-party evaluation organizations.